Source: BioPortfolio

CaroGen: CaroGen Corp Pharmaceuticals Healthcare Deals and Alliances Profile Updated 23022017 Prices from USD $250

SummaryCaroGen Corp CaroGen which focuses on the development and commercialization of nanoparticle therapeutic vaccines. The company utilizes its viruslike vesicle VLV platform technology a proprietary replication competent to develop nano particle therape...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bijan Almassian's photo - President & CEO of CaroGen

President & CEO

Bijan Almassian

CEO Approval Rating

83/100

Read more